Abstract
Background There is evidence that arsenic is a late-stage human lung carcinogen.
Aims To investigate lung cancer risks in a cohort of cadmium recovery workers in relation to period from ceasing exposure to arsenic.
Methods The mortality experience (1940-2001) of a cohort of 625 male workers from a US cadmium recovery plant was compared with expectations based on US national mortality rates.
Results There was a statistically significant (P <0.05) negative trend in lung cancer standardized mortality ratios in relation to period from ceasing arsenic exposure.
Conclusions The findings are consistent with the hypothesis that arsenic is a late-stage human carcinogen.
| Original language | English |
|---|---|
| Pages (from-to) | 264-266 |
| Journal | Occupational Medicine |
| Volume | 59 |
| Issue number | 4 |
| DOIs | |
| Publication status | Published - 30 Mar 2009 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Arsenic
- lung cancer
- cadmium
- cohort study
Fingerprint
Dive into the research topics of 'Lung cancer mortality in arsenic-exposed workers from a cadmium recovery plant'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver